US Global Jets ETF vs Revvity Inc — how do they compare? US Global Jets ETF trades at $30.55, while Revvity Inc trades at $110.1 (market cap $11.87B). The key difference: Revvity Inc pays a 0.26% dividend while US Global Jets ETF pays none. Which is the better fit depends on your goals.
| JETS | RVTY | |
|---|---|---|
Sector | Sector/Thematic | Technology |
52-Week High | $33.34 | $117.75 |
52-Week Low | $23.12 | $82.26 |
Market Cap | — | $11.87B |
Enterprise Value | — | $14.36B |
Dividend Yield | — | 0.26% |
Signals from Pluang's Aura AI — not financial advice
JETS trades at $30.58, up 0.39% with a mixed technical outlook showing bullish overall signals but bearish moving averages. The ETF faces headwinds from rising fuel costs, with U.S. airlines spending $6.66 billion on jet fuel in May 2026 (U.S. Transportation Department, 2026-07-07), though lower oil prices recently provided some relief. Recent news highlights volatility from Middle East conflicts and competitive pressure from defense-focused ETFs.
Outlook remains cautious due to cyclical exposure and fuel cost sensitivity. Investment opportunity hinges on sustained oil price declines, but risks include geopolitical tensions and airline profit pressures. Analyst sentiment is neutral with a Hold rating, emphasizing the ETF's concentration in industrials and high volatility.
RVTY trades at $106.44, down 3.37% today, with a bullish technical outlook despite near-term weakness. The company maintains stable revenue around $2.9B with consistent earnings beats, though valuation multiples appear elevated with a P/E of 51. Recent AI product launches and FDA clearances demonstrate innovation in life sciences and diagnostics. Analyst consensus remains positive with a $111.43 price target and no sell ratings among 29 covering firms.
The stock presents a growth opportunity with strong analyst support and technological innovation, but faces risks from margin pressure and China market exposure. Current levels near support at $105 offer potential entry, though the high P/E requires sustained earnings growth to justify valuation. Upcoming Q2 earnings on August 4, 2026 will be critical for near-term direction.
Trailing returns across standard periods
JETS provides targeted exposure to the global airline industry, including commercial airlines, aircraft manufacturers, and airport operators. It focuses on major U.S. and international carriers like Delta, United, and American Airlines.
Read more on JETS →Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →